No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference
3 Health Care Stocks Moving In Thursday's Intraday Session
H.C. Wainwright Maintains OKYO Pharma(OKYO.US) With Buy Rating, Maintains Target Price $7
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients With Neuropathic Corneal Pain
OKYO Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
OKYO Pharma Analyst Ratings
Unlock the Full List